Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 2/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N,N-Dimethylethanaminium SCHEMBL446423 | 1.00 | CHRM1 (0.30) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Trimethylammonium SCHEMBL444001 | 0.91 | TDP1 (0.32) | — | |
| Trimethylammonium SCHEMBL3037482 | 0.91 | TDP1 (0.32) | — | |
| Trimethylammonium SCHEMBL28049015 | 0.89 | TDP1 (0.31) | — | |
| Trimethylammonium SCHEMBL3296121 | 0.89 | TDP1 (0.31) | — | |
| Trimethylammonium SCHEMBL3296379 | 0.89 | TDP1 (0.31) | — | |
| SCHEMBL297210 | 0.89 | — | — | |
| SCHEMBL297211 | 0.89 | — | — | |
| SCHEMBL14982855 | 0.89 | — | — | |
| SCHEMBL28049103 | 0.87 | CHRM2 (0.32) | CHRM1CHRM2CHRM4CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120201773-A1 | UNENCUMBERING HAIR TREATMENT PRODUCT | HENKEL AG & CO. KGAA (DE) | 2012-08-09 | — | — | US | disclosed |
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HENKEL AG & CO. KGAA (DE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215604-A1 | Cosmetic Compositions with Chitosan and Silicone Elastomers | HDAC10, HDAC1, HDAC3 | CHRM1 2879/4885CHRM2 2774/4885CHRM4 4182/4885 |
| US-20120201773-A1 | UNENCUMBERING HAIR TREATMENT PRODUCT | POLR1C, SPTAN1, SMURF1 | CHRM1 4703/4885CHRM2 4749/4885CHRM4 4785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.